Integrating redox biomarkers, mitochondrial assays, and measures of immune reactivity into future clinical trials will be essential to determine the full systemic impact of improving detoxification in this uniquely vulnerable population
However, reduced fluid intake, digestive side effects, and rapid weight loss may indirectly increase the risk in some individuals, making hydration an important part of treatment
However, pain can pop back up in the future and is often a sign that the previous injury has not fully healed
Key pharmacological effects include: Glucose-dependent insulin secretion Enhanced pancreatic beta-cell insulin release only when blood glucose is elevated, reducing hypoglycemia risk Suppression of glucagon secretion Decreased hepatic glucose production from pancreatic alpha cells Delayed gastric emptying Slowed movement of food from the stomach to the small intestine Central appetite regulation Reduced hunger and increased satiety through hypothalamic pathways The delayed gastric emptying effect is particularly significant and represents both a therapeutic mechanism and a potential source of adverse effects
Semaglutide (Wegovy, Ozempic, oral Wegovy): A GLP-1 receptor agonist that targets a single hormone pathway
